Related Experiment Videos
Multiple genes, one polypeptide chain
1Oklahoma Medical Research Foundation, Molecular Immunogenetics Program, 825 Northeast 13th Street, Oklahoma City, OK 73104, USA. jdonald-capra@omrf.ouhsc.edu
Journal of Immunology (Baltimore, Md. : 1950)
|November 24, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Corrigendum: Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.
Nature protocols·2014
Same author
Human monoclonal antibodies as a new class of antiinfective compounds.
Clinical & developmental immunology·2013
Same author
Funding agencies and disease organizations: resources and recommendations to facilitate ALS clinical research.
Amyotrophic lateral sclerosis & frontotemporal degeneration·2013
Same author
Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.
Nature protocols·2009
Same author
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.
Blood·2008
Same journal
Optineurin restrains IL-17-associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection.
Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal
Crystal structure and immune single-cell atlas provide insights into the functional divergence of type I IFNs in fish.
Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal
Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.
Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal
Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.
Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal
FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.
Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal
An MR1-specific nanobody capable of blocking MR1T cell activation.
Journal of immunology (Baltimore, Md. : 1950)·2026